By Route of Administration, the Parenteral Segment dominates, while the Oral Segment Shows Rapid Growth The parenteral segment held the largest revenue share of approximately 88.80% in 2025, due to semaglutide being currently only available in injectable over
Hypoglycaemia can occur with GLP-1 agonists, especially if used alongside sulfonylureas or insulin.3 Diabetics on GLP-1 Agonists can also present with episodes of hyperglycaemia and DKA.3 In such cases, it is important to look beyond the acute management and consider whether problems with regular access to medication is a contributing factor
International Journal of Molecular Medicine
Understanding how these medications work inside the full weight ecosystem is an essential part of responsible, trauma-informed care
Brain Res Brain Res Rev 23(12):134143 Mnch G, Schinzel R, Loske C, Wong A, Durany N, Li JJ, Vlassara H, Smith MA, Perry G, Riederer P (1998) Alzheimers diseasesynergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts
Common: may affect up to 1 in 10 people feeling dizzy upset stomach or indigestion burping gas (flatulence) bloating of the stomach inflamed stomach (gastritis) the signs include stomach ache, feeling sick (nausea) or being sick (vomiting) reflux or heartburn also called gastro-oesophageal reflux disease gallstones hair loss injection site reactions low blood sugar (hypoglycaemia) in patients with diabetes